Details of the Drug

General Information of Drug (ID: DMWQIO3)

• Drug Name: Denintuzumab mafodotin

Indication

Disease Entry	ICD 11	Status	REF
Diffuse large B-cell lymphoma	2A81	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 86278355
  TTD ID: D01QMK

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)